1001353-82-7 Usage
Uses
Used in Organic Synthesis:
2,4-dichloropyrrolo[2,1-f][1,2,4]triazine-7-carbaldehyde serves as a valuable building block in organic synthesis, enabling the creation of a variety of compounds with diverse applications. Its unique structure allows for the formation of new chemical entities through reactions with other molecules, thus expanding the scope of chemical research and development.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 2,4-dichloropyrrolo[2,1-f][1,2,4]triazine-7-carbaldehyde is utilized for the synthesis of biologically active compounds. Its structural features make it a promising candidate for the development of new pharmaceuticals, potentially leading to advancements in the treatment of various diseases and medical conditions.
Used in Material Science:
2,4-dichloropyrrolo[2,1-f][1,2,4]triazine-7-carbaldehyde also finds applications in material science, where it can be incorporated into the design and synthesis of novel materials with specific properties. Its versatility in chemical reactions allows for the engineering of materials with tailored characteristics for use in various industries.
Used as a Chemical Intermediate:
2,4-dichloropyrrolo[2,1-f][1,2,4]triazine-7-carbaldehyde acts as a chemical intermediate in the production of a multitude of products across different sectors. Its role in the synthesis of other compounds makes it an essential component in the manufacturing process, contributing to the development of new and innovative products.
Check Digit Verification of cas no
The CAS Registry Mumber 1001353-82-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,1,3,5 and 3 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1001353-82:
(9*1)+(8*0)+(7*0)+(6*1)+(5*3)+(4*5)+(3*3)+(2*8)+(1*2)=77
77 % 10 = 7
So 1001353-82-7 is a valid CAS Registry Number.
1001353-82-7Relevant articles and documents
PYRROLOTRIAZINE KINASE INHIBITORS
-
, (2011/04/19)
The invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.
PYRROLOTRIAZINE KINASE INHIBITORS
-
Page/Page column 32, (2008/06/13)
The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of such as TrkA, TrkB, TrkC, Jak2, Jak3 and CK2, thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.
